| Financial Year |
March 31 2023 |
| Monetary Funds |
569,910,139.92 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
33,200,000.00 |
| Accounts Receivable |
167,135,540.62 |
| Advances to Suppliers |
34,898,109.78 |
| Other Receivables |
6,257,462.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
301,246,711.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,603,327.71 |
| Total Current Assets |
1,131,251,291.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
893,220,868.82 |
| Under-construction Projects |
199,603,671.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
263,806,082.49 |
| R&D expenses |
-- |
| Goodwill |
137,713,116.92 |
| Long-Term Deferred and Prepaid Expenses |
43,205,751.85 |
| Deferred Income Tax Assets |
12,887,857.05 |
| Other Non-Current Assets |
130,251,082.05 |
| Sub-Total of Non-Current Assets |
1,686,686,520.66 |
| Total Assets |
2,817,937,812.57 |
| Short-Term Loans |
171,827,095.39 |
| Trading Financial liabilities |
-- |
| Notes Payable |
454,522,785.95 |
| Accounts Payable |
172,998,245.65 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,305,890.99 |
| Taxes Payable |
4,996,803.97 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
63,770,102.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
18,461,173.78 |
| Other Current Liabilities |
195,489.26 |
| Sub-Total of Current Liabilities |
922,331,263.17 |
| Long-term Loans |
112,410,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
35,180,075.44 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
195,091,089.13 |
| Total Liabilities |
1,117,422,352.30 |
| Paid-In Capital(Or Share Stock) |
120,000,000.00 |
| Capital Surplus |
976,478,630.29 |
| Surplus Reserve |
47,881,513.52 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
387,345,998.32 |
| Minority Stockholder's Interest |
169,190,870.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,531,324,589.90 |
| Owner's Equity（Stockholder's Equity） |
1,700,515,460.27 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,817,937,812.57 |
